136
Participants
Start Date
October 31, 2011
Primary Completion Date
February 28, 2013
Study Completion Date
June 30, 2013
Endoscopy
Only patients undergoing endoscopy for clinical reasons will be included in the study, i.e. no endoscopies will be performed solely for study reasons. For the purposes of our study, endoscopy serves to determine the degree of inflammation and no additional biopsies are taken. Blood for CRP and ficolin-2 analysis will be taken through the Venflon® installed for endoscopy.
Endoscopy
Only patients undergoing endoscopy for clinical reasons will be included in the study, i.e. no endoscopies will be performed solely for study reasons. For the purposes of our study, endoscopy serves to determine the degree of inflammation and no additional biopsies are taken. Blood for CRP and ficolin-2 analysis will be taken through the Venflon® installed for endoscopy.
Service de gastro-entérologie et hépatologie, CHUV Lausanne, Lausanne
DCR, Gastroenterology, Bern, University of Bern, Bern
Gastroenterology and Hepatology, Basel University Hospital, Basel
University Hospital, Basel, Switzerland
OTHER
University of Lausanne Hospitals
OTHER
Swiss IBD Cohort Study
UNKNOWN
Merck Sharp & Dohme LLC
INDUSTRY
University of Bern
OTHER